Part 7/10:
While these experiments were initially conducted in cell cultures and animal models, the results are promising enough to warrant further investigation. Currently, clinical trials are underway to test this combination in humans. Although no conclusive evidence exists yet, early data and related studies suggest this approach could become an important adjunct for KRAS-mutant cancers.
Most importantly, it's crucial to understand that this isn’t an outright cure yet. The research recognizes that not all cancers are susceptible, and individual genetic profiling remains essential for personalized treatment.
Practical Takeaways and Caution
If you or your loved one is diagnosed with a KRAS-mutant cancer, these findings offer a potential framework to discuss with healthcare providers: